Home > Journals > Minerva Gastroenterologica e Dietologica > Past Issues > Minerva Gastroenterologica e Dietologica 2006 June;52(2) > Minerva Gastroenterologica e Dietologica 2006 June;52(2):187-93

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

  AN UPDATE ON HEPATITIS B VIRUS INFECTION 

Minerva Gastroenterologica e Dietologica 2006 June;52(2):187-93

Copyright © 2006 EDIZIONI MINERVA MEDICA

language: English

Chronic hepatitis C infection in children

Broide E., Kimchi N. A., Scapa E.

Institute of Gasteroenterology Asaf Harofeh Medical Center, Zerifin affiliated to Sackler School of Medicine Tel-Aviv University, Israel


PDF


Hepatitis C virus infection may differ in the pediatric age group with respect to transmission, natural history and response to treatment. Most infected children develop chronic hepatitis but with a relatively mild course of the disease. The most efficient transmission of hepatitis C virus is through direct percutaneous exposure to infected blood or blood products. However, the major risk factor for acquisition of hepatitis C virus in children at present is maternal-infant transmission. The rate of progression to advanced liver disease seems to be more rapid in post transfusional and vertically acquired hepatitis C virus infection than in sporadic hepatitis C virus infection acquired postnatally, or in those without known risk factors. There is a wide variety of histopathological expression, depending on the geographical distribution of the different countries. Treatment for hepatitis C virus in children has not yet been approved. However, combination treatment with peginterferon-alpha-2b with ribavirin shows encouraging results and is generally well tolerated. More randomized controlled trials are needed in the future to optimize the approach to hepatitis C virus infection in children.

top of page